Ibandronic Acid
Back to searchMolecule Structure
Scientific Name
Ibandronic Acid
Description of the Drug
Ibandronate is a bisphosphonate used to treat osteoporosis in postmenopausal women.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00710
http://www.drugbank.ca/drugs/DB00710
Brand Name(s)
Bondronat, Bonviva, Iasibon, Quodixor
Company Owner(s)
Hoffmann La Roche Inc, Apotex Inc, Mylan Laboratories Ltd, Sagent Pharmaceuticals Inc, Macleods Pharmaceuticals Ltd, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Sun Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Inc, Accord Healthcare Inc, Nang Kuang Pharmaceutical Co Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Farnesyl diphosphate synthase | SINGLE PROTEIN | INHIBITOR | CHEMBL1782 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL9183 | |||
| PharmGKB | PA10270 | |||
| Human Metabolome Database | HMDB0014848 | |||
| DrugBank | DB00710 | |||
| PubChem: Thomson Pharma | 14899229 | |||
| PubChem | 146015366 | 60852 | ||
| LINCS | LSM-4279 | |||
| Nikkaji | J476.066B | |||
| PDBe | BFQ | |||
| BindingDB | 12577 | |||
| EPA CompTox Dashboard | DTXSID5048340 | |||
| DrugCentral | 1404 | |||
| Brenda | 212815 | 11258 | ||
| ChemicalBook | CB4500836 | |||
| Guide to Pharmacology | 3059 | |||
| rxnorm | IBANDRONATE SODIUM | IBANDRONATE | IBANDRONIC ACID | BONIVA |
| ZINC | ZINC000001533877 |
